Dr. Reddy’s Laboratories Launches Celevida Wellness, a Direct-to-Consumer E-Commerce Platform
Dr. Reddy’s Laboratories Ltd., a leading global pharmaceutical company, has expanded its market approach with the introduction of Celevida Wellness, its first direct-to-consumer e-commerce platform. This move into the digital commerce space is a strategic response to the growing Healthcare E-Commerce market, which is projected to surpass USD 994.2 billion by 2030 according to Vantage Market Research, boasting a compound annual growth rate of 16.2% from 2023.
Founded in Hyderabad, India, by Dr. Kallam Anji Reddy in 1984, Dr. Reddy’s Laboratories has been at the forefront of innovation, supplying APIs to the U.S. and establishing a global presence in the generics pharmaceutical market. The company has a strong presence in highly regulated markets such as the U.S. and is listed on the NYSE, with a focus on key markets like India, Russia, China, Brazil, and Europe.
Celevida Wellness caters to the high demand for drugs and the expanding e-commerce market, offering a range of products and services, including nutritional drinks, weight management capsules, and diabetic-friendly sugar substitutes. The platform also plans to provide personalized dietary advice and health tracking tools in the near future.
With the increased reliance on online healthcare services due to the COVID-19 pandemic, consumers have turned to digital platforms for prescription medications and health products. Direct-to-Consumer channels allow Dr. Reddy’s Laboratories to establish a closer connection with customers, using consumer data to drive efficiencies and create personalized, relevant communication. This approach aims to increase the repeat rate of purchases and align with the growing trend of consumers seeking to proactively manage their health through digital platforms.
Celevida Wellness is set to serve the rising diabetic population in India, as well as capitalize on the consumer shift towards digital health product purchases, accelerated by the pandemic and the move away from physical retail.
By capitalizing on the expansion of the global healthcare market and leveraging e-commerce infrastructure, Dr. Reddy’s Laboratories aims to offer efficient and scalable solutions to a larger customer base, particularly health-conscious consumers. This move reflects the company’s commitment to innovation, accessibility, and patient care in the digital age of the pharmaceutical industry.
The platform is not just an e-commerce initiative; it represents Dr. Reddy’s aim to integrate healthcare seamlessly with technology, delivering wellness directly to consumers and contributing to the digital transformation of the global healthcare industry.
*[Original article © 2023 TECHTIMES.com. Do not reproduce without permission. This is a contributed article and the content does not necessarily represent the views of TechTimes.]*
I have over 10 years of experience in the cryptocurrency industry and I have been on the list of the top authors on LinkedIn for the past 5 years. I have a wealth of knowledge to share with my readers, and my goal is to help them navigate the ever-changing world of cryptocurrencies.
